The record
Written from the 1 report below. Nothing here is unsourced.
- A senior Telangana official, Sarvesh Singh, Director and CEO of Lifesciences and Pharma, urged the pharmaceutical industry at a CII Telangana conference to treat safety as a driver of competitiveness rather than just a compliance requirement.
- He called for a proactive safety culture through continuous incident reporting and use of advanced technologies such as AI, IoT, digital twins, wearables and drone-based inspections.
- He said Telangana, as the Life Sciences and vaccine capital of the world, has a greater responsibility and should aim to be the safest destination for pharmaceutical manufacturing.
- Other industry leaders echoed the need to embed safety by design and build a resilient, globally competitive Life Sciences sector.
What to watch next
- Concrete measures or policies from Telangana to promote proactive safety culture and technology adoption in pharma manufacturing
- Follow-up conferences or initiatives in the CII Telangana series on safety
Coverage1
1 report
English national1
All filed from India
Named India · Chakravarthi AVPS · CII Telangana · CII Telangana Pharma and Life Sciences Panel · R. Sivaprasad Reddy · Sarvesh Singh · Telangana government
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.